LINE LAWSUIT ALERT: Lineage, Inc. is Being Sued for Securities Violations after Downturn Leads to 17% Stock Drop – Investors Urged to Contact BFA

LINE LAWSUIT ALERT: Lineage, Inc. is Being Sued for Securities Violations after Downturn Leads to 17% Stock Drop – Investors Urged to Contact BFA GlobeNewswire September 24, 2025 NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. […]

SLP INVESTOR ALERT: Simulations Plus, Inc. is Being Investigated for Securities Fraud after Impairment Charge Leads to 26% Stock Drop – Investors Urged to Contact BFA

SLP INVESTOR ALERT: Simulations Plus, Inc. is Being Investigated for Securities Fraud after Impairment Charge Leads to 26% Stock Drop – Investors Urged to Contact BFA GlobeNewswire September 24, 2025 NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ:

COTY INVESTOR ALERT: Coty Inc. is Being Investigated for Securities Fraud after Excess Inventory Levels Lead to 21% Stock Drop – Investors Urged to Contact BFA

COTY INVESTOR ALERT: Coty Inc. is Being Investigated for Securities Fraud after Excess Inventory Levels Lead to 21% Stock Drop – Investors Urged to Contact BFA GlobeNewswire September 24, 2025 NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY)

JHX INVESTOR ALERT: James Hardie Industries plc is Being Investigated for Securities Fraud after Q1 Earnings Leads to 34% Stock Drop – Investors Urged to Contact BFA

JHX INVESTOR ALERT: James Hardie Industries plc is Being Investigated for Securities Fraud after Q1 Earnings Leads to 34% Stock Drop – Investors Urged to Contact BFA GlobeNewswire September 24, 2025 NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into James Hardie Industries

IQST – IQSTEL Celebrates 120 Days on Nasdaq With Institutional Investors, Analyst Coverage, and Cycurion Dividend Driving AI & Digital Expansion

12 institutions now hold ~4% of IQST shares; Litchfield Hills Research issues $18 price target as IQSTEL accelerates high-margin growth strategy IQSTEL Inc. (NASDAQ: IQST), a Global Connectivity, AI & Digital Corporation, today announced the release of its 120-Day Nasdaq Shareholder Letter, highlighting the Company's performance, growth trajectory, and increasing institutional recognition since uplisting to

The New Job Hunt Reality: More Seekers, Longer Timelines, Greater Required Flexibility

Twenty-five percent expect a six-month search, and 83% are willing to take different roles to secure work. The labor market is sending mixed signals, and America's job seekers are taking notice. While employers may feel confident, workers are bracing for a tougher road ahead, and many are already making moves. https://mma.prnewswire.com/media/2779067/Express_Employment_Professionals.jpg The latest Express Employment

Terra Clean Energy Corp. Enters into Definitive Agreements to Acquire Uranium Claims on The San Rafael Swell, Utah, United States

Terra Clean Energy Corp. Enters into Definitive Agreements to Acquire Uranium Claims on The San Rafael Swell, Utah, United States GlobeNewswire September 24, 2025 Vancouver B.C., Sept. 24, 2025 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0), is pleased to announce that, further to its press

OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase

(NASDAQ:ONMD), MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with Medcase, a worldwide network of healthcare professionals focused on medical data annotation. This collaboration establishes a new market entry point for OneMedNet and opens a

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1

(NASDAQ:AKTX), Data highlights ability of Akari's ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression No current therapies have proven to be effective in AR-V7 driven tumors BOSTON and LONDON, Sept. 24, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology

BRBR INVESTOR ALERT: BellRing Brands is Being Investigated for Securities Fraud after Inventory Levels Lead to 18% Stock Drop – Investors Urged to Contact BFA

(NYSE:BRBR), NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing Being Investigated?

Scroll to Top